Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers

PURPOSE OF REVIEW: Immune checkpoint blockade targeting PD-1 and PD-L1 improves immune recognition of tumor cells but had only modest success in gynecological cancers as monotherapy. Growing focus has been placed on combination immunotherapy strategies to overcome this resistance, and this review se...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying L., Zamarin, Dmitriy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Gynecologic Cancers (NS Reed, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244932/
https://www.ncbi.nlm.nih.gov/pubmed/30421009
http://dx.doi.org/10.1007/s11912-018-0740-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244932/
https://www.ncbi.nlm.nih.gov/pubmed/30421009
http://dx.doi.org/10.1007/s11912-018-0740-8

Ejemplares similares